Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate

Oncogene

Volumn 13, Issue 1, 1996, Pages 205-211

  Milne, D M ^a   McKendrick, L ^a   Jardine, L J ^a   Deacon, E ^b   Lord, J M ^b   Meek, D W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

p53; PAb421 epitope; Phosphorylation; Protein kinase C

Indexed keywords

DNA BINDING PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHORUS 32; PROTEIN KINASE C; PROTEIN P53; SERINE; THREONINE;

ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; TUMOR SUPPRESSOR GENE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DNA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; PHOSPHORYLATION; PHOSPHOSERINE; PHOSPHOTHREONINE; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; TETRADECANOYLPHORBOL ACETATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029993161     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Baudier J, Delphin C, Grunwald D, Khochbin S and Lawrence JJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 11627-11631.
2. Boyle WJ, van der Geer P and Hunter T. (1991). Methods Enzymol., 201, 110-149.
3. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
4. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature. 362, 849-852.
5. Delphin C and Baudier J. (1994). J. Biol. Chem., 269, 29579-29587.
6. Donehower LA and Bradley A. (1993). Biochem, Biophvs. Acta., 1155, 181-205.
7. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
8. Hupp TR and Lane DP. (1994). Cold Spring Harbor Symp. Quant. Biol., 59, 195-206.
9. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
10. Kemp BE and Pearson RB. (1990). Trends in Biochem. Sci., 15, 342-346.
11. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B. (1992). Science, 256, 827-830.
12. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
13. Lane DP, (1992). Nature, 358, 15-16.
14. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. (1992). Cell, 70, 923-935.
15. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993). Nature, 362, 847-849.
16. Maltzman W and Czyzyk L. (1984). Mol.Cell. Biol., 4, 1689-1694.
17. McKendrick L and Meek DW. (1994). Cell.Mol. Biol. Res.,40, 555-561.
18. Meek DW. (1994). Seminars in Cancer Biology, 5, 203-210.
19. Meek DW and Eckhart W. (1988). Mol.Cell.Biol., 8, 461-465.
20. Meek DW,Simon S, Kikkawa U and Eckhart W. (1990). Embo J., 9, 3253-3260.
21. Milne DM, Campbell DG, Caudwell FB and Meek DW. (1994). J. Biol. Chem., 269, 9253-9260.
22. Milner J and Watson JV. (1990). Oncogens, 5, 1683-1690.
23. Nishizuka Y. (1992). Science, 258, 607-614.
24. Scharer E and Iggo R. (1992). Nucleic Acids Res., 20, 1539-1545.
25. Shaw P, Freeman J, Bovey R and Iggo R. (1996). Oncogene, 12, 921-930.
26. Soussi T, Caron de Fromentel C and May P. (1990). Oncogene, 5, 945-952.
27. Takenaka I, Morin F, Seizinger BR and Kley N. (1995). J. Biol. Chem., 270, 5405-5411.
28. Ullrich SJ, Mercer WE and Appella E. (1992). Oncogene, 7, 1635-1643.
29. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. (1992). Cell., 70, 937-948.